BlackRock MuniHoldings California Quality Fund, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MUC research report →
Price Chart
About the company
The BlackRock MuniHoldings California Quality Fund, Inc. (MUC) is a closed-end investment vehicle initially brought to market by BlackRock, Inc. Its day-to-day management falls under the purview of BlackRock Advisors, LLC.
- CEO
- Charles Choon Sik Park
- IPO
- 1998
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on MUC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $925.36M
- P/E
- 10.10
- PEG
- 0.01
- P/S
- 9.12
- P/B
- 0.85
- EV/EBITDA
- 16.65
- Div Yield
- 6.58%
- Gross Margin
- 83.55%
- Op Margin
- 113.49%
- Net Margin
- 90.58%
- ROE
- 7.17%
- ROIC
- 4.65%
Latest fiscal year · YoY change
- Revenue
- $100.79M+21.9%
- Gross Profit
- $84.21M+1.8%
- Op Income
- $114.38M
- Net Income
- $91.30M+223.0%
- EPS
- $0.96+221.5%
- OCF Growth
- +432.8%
- FCF Growth
- +432.8%
- 52W High
- $11.16
- 52W Low
- $9.51
- 50D MA
- $10.34
- 200D MA
- $10.67
- Beta
- 0.67
- RSI (14)
- 40
- Avg Volume
- 533.59K
No earnings-call transcripts are available for MUC yet.
- Free Float
- 100.0%
- Shares Outstanding
- 94.18M
- Float Shares
- 94.18M
of shares held by institutions
136 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Morgan Stanley | 7.40M | ▲ 9.81K |
| Karpus Management, Inc. | 4.60M | ▼ 776.32K |
| Guggenheim Capital LLC | 2.60M | ▼ 117.79K |
| Bank Of America Corp | 2.41M | ▲ 136.66K |
| Advisors Asset Management, Inc. | 2.31M | ▲ 314.16K |
| Robinson Capital Management, LLC | 1.12M | 0 |
| Allspring Global Investments Holdings, LLC | 1.10M | 0 |
| Rivernorth Capital Management, LLC | 1.07M | ▼ 1.19M |
| Wells Fargo & Company/Mn | 963.27K | ▲ 41.71K |
| Lpl Financial LLC | 732.75K | ▲ 56.39K |
| Hennion & Walsh Asset Management, Inc. | 709.30K | ▲ 35.33K |
| Sanctuary Advisors, LLC | 486.47K | ▲ 18.69K |
Held by 4 ETFs
Biggest fund positions in MUC by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 8, 26 | Mahoney Francis C. | other | 0 |
| Aug 1, 26 | Park Charles | other | 0 |
| Feb 9, 26 | Harris Stayce D. | other | 11 |
| May 8, 25 | Minar Stephen Thomas | other | 0 |
| Oct 29, 24 | Harris Stayce D. | buy | 10 |
| Sep 27, 24 | WELLS FARGO & COMPANY/MN | other | 5,264 |
| May 3, 24 | WELLS FARGO & COMPANY/MN | other | 5,264 |
| May 3, 24 | WELLS FARGO & COMPANY/MN | other | 5,264 |
| Sep 9, 23 | Steinmetz Arthur Philip | other | 0 |
| Jul 1, 23 | Wasserman Aaron David | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MUC coverage
Recent articles, reports, and earnings notes.
No research on MUC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MUC report →Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)
globenewswire.com · Oct 1
Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026
prnewswire.com · Oct 1
ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers
globenewswire.com · May 7
MUC: Has Seen A Great Return, With More Gains Likely To Come
seekingalpha.com · Apr 11
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
prnewswire.com · Apr 10
BlackRock MuniHoldings California Quality Fund, Inc. $MUC Position Increased by Allspring Global Investments Holdings LLC
defenseworld.net · Apr 7
ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting
globenewswire.com · Mar 17
BlackRock MuniHoldings California Quality Fund, Inc. (NYSE:MUC) Short Interest Up 404.0% in December
defenseworld.net · Jan 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.